ACKR3 agonist 1 (compound 27) is a selective ACKR3 agonist (EC50=69 nM, Emax=82%) that inhibits platelet aggregation. ACKR3 agonist 1 is metabolically stable and non-cytotoxic, and has the potential to inhibit platelet-mediated thrombosis[1].
Molecular Weight:
406.58
Formula:
C25H30N2OS
Target:
CXCR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
